Skip to product information
1 of 1

BAYER SpA

Lasonil painkiller 10% gel 50g

Lasonil painkiller 10% gel 50g

Regular price €10,35
Regular price €10,35 Sale price €10,35
Sale Sold out
Tax included. Shipping calculated at checkout.

Ricevi 10 punti per l'acquisto di questo articolo - NON USARE sconti di associazioni o partner commerciali o i Punti così ottenuti verranno sottrattiUnisciti a noi per ricevere

Logo Farmaci da banco
 More payment options

042154017

042154017

View full details

Lasonil antidolore 10% gel 50g is a topical treatment formulated to relieve pain associated with bruises, sprains, myalgia, muscle strains and stiff neck. This gel contains Ibuprofen lysine salt , an active ingredient known for its anti-inflammatory and analgesic properties. Its local application allows for a targeted action, reducing inflammation and pain directly in the affected area. Lasonil antidolore is ideal for those looking for quick and effective relief from muscle and joint pain. The gel formulation allows for rapid absorption and easy application, making it a practical option for the treatment of pain. With a 10% ibuprofen content, this product is designed to offer powerful and long-lasting relief.

ACTIVE INGREDIENTS

Active ingredients contained in Lasonil antidolore 10% gel 50g - What is the active ingredient of Lasonil antidolore 10% gel 50g?

100 g of gel contain: Active ingredient : Ibuprofen lysine salt 10 g Excipients : Sodium methyl parahydroxybenzoate, sodium ethyl parahydroxybenzoate. For the full list of excipients, see section 6.1.

EXCIPIENTS

Composition of Lasonil antidolore 10% gel 50g - What does Lasonil antidolore 10% gel 50g contain?

Isopropanol, hydroxyethylcellulose, sodium methyl parahydroxybenzoate, sodium ethyl parahydroxybenzoate, glycerol, lavender essence, purified water.

DIRECTIONS

Therapeutic indications Lasonil antidolore 10% gel 50g - Why is Lasonil antidolore 10% gel 50g used? What is it for?

Local treatment of bruises, sprains, myalgia, muscle tears, stiff neck.

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Lasonil antidolore 10% gel 50g - When should Lasonil antidolore 10% gel 50g not be used?

- Hypersensitivity to the active substance or to any of the excipients. Due to the possibility of cross-sensitization, the medicinal product should not be administered to patients in whom acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs have caused asthma, rhinitis, urticaria or other allergic manifestations. - Pregnancy. - Breastfeeding. - Children and adolescents under 14 years of age.

DOSAGE

Quantity and method of taking Lasonil antidolore 10% gel 50g - How to take Lasonil antidolore 10% gel 50g?

2-4 applications per day on the painful area. Elderly patients should stick to the minimum dosages indicated above. Apply a thin layer of gel on the area to be treated with a light massage. Use the medicine for the shortest possible period. Wash your hands thoroughly and for a long time after application.

CONSERVATION

Storage Lasonil anti-pain 10% gel 50g - How to store Lasonil anti-pain 10% gel 50g?

No special instructions required

WARNINGS

Warnings Lasonil anti-pain 10% gel 50g - About Lasonil anti-pain 10% gel 50g it is important to know that:

It is advisable to avoid applying LASONIL ANTIDOLORE to open wounds or skin lesions. The use of LASONIL ANTIDOLORE, as with any drug that inhibits the synthesis of prostaglandins and cyclooxygenase, is not recommended in women who intend to become pregnant. The administration of LASONIL ANTIDOLORE must be suspended in women who have fertility problems or who are undergoing fertility investigations. The use of LASONIL ANTIDOLORE, especially if prolonged, may give rise to local sensitization phenomena: at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity, interrupt the treatment and adopt adequate therapeutic measures. To avoid more serious hypersensitivity or photosensitivity phenomena, the patient must not expose himself to direct sunlight, including solarium, during treatment and for two weeks thereafter (see paragraph 4.8). Do not use LASONIL ANTIDOLORE together with another NSAID or, in any case, do not use more than one NSAID at a time. Severe skin reactions Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk in the early stages of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Acute generalized exanthematous pustulosis (AGEP) has been reported in relation to medicinal products containing ibuprofen. Ibuprofen should be discontinued at the first appearance of signs and symptoms of severe skin reactions, such as rash, mucosal lesions, or any other sign of hypersensitivity. Important information about some of the excipients of LASONIL ANTIDOLORE : the medicine contains sodium methyl parahydroxybenzoate and sodium ethyl parahydroxybenzoate which may cause allergic reactions (even delayed).

INTERACTIONS

Interactions Lasonil antidolore 10% gel 50g - Which medicines or foods can modify the effect of Lasonil antidolore 10% gel 50g?

The paucity of data and the uncertainties regarding their application to the clinical situation do not allow to draw definitive conclusions on possible interactions with other drugs for the continuous use of ibuprofen; no clinically relevant interactions have been found with the occasional use of ibuprofen. It should be taken into account, in any case, that Ibuprofen can increase the effects of anticoagulants such as warfarin.

SIDE EFFECTS

Like all medicines, Lasonil antidolore 10% gel 50g can cause side effects - What are the side effects of Lasonil antidolore 10% gel 50g?

Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms. Skin and subcutaneous tissue disorders Skin reactions with erythema, itching, irritation, sensation of heat or burning and contact dermatitis have been reported with some propionic acid derivatives NSAIDs for local or transdermal use. Some cases of bullous eruptions of varying severity, including Stevens Johnson syndrome, and toxic epidermal necrolysis have also been reported (very rarely). Frequency not known: - Acute generalised exanthematous pustulosis (AGEP) (see section 4.4) - Photosensitivity reactions (see section 4.4) Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

OVERDOSE

Overdose Lasonil antidolore 10% gel 50g - What are the risks of Lasonil antidolore 10% gel 50g in case of overdose?

No cases of overdose have been reported.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Lasonil anti-pain 10% gel 50g

The use of LASONIL ANTIDOLORE is contraindicated during pregnancy and breastfeeding. Inhibition of prostaglandin synthesis may adversely affect pregnancy and/or embryo/fetal development. Results of epidemiological studies suggest an increased risk of miscarriage and cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1% to approximately 1.5%. The risk was believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo/fetal mortality. In addition, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose • the fetus to: - cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); - renal dysfunction, which may progress to renal failure with oligo-hydroamniosis; • the mother and the neonate, at the end of pregnancy, to: - possible prolongation of bleeding time, and anti-aggregating effect which may occur even at very low doses; - inhibition of uterine contractions resulting in delayed or prolonged labor.

DRIVING AND USE OF MACHINERY

Taking Lasonil antidolore 10% gel 50g before driving or using machines - Does Lasonil antidolore 10% gel 50g affect driving or using machines?

The medicine does not alter the ability to drive vehicles or use machines.

  • HELP CENTER

  • SHIPPING

    Shipping in Italy 24/48H
    Delivery also on Saturday and Sunday
    Free over €49.90


    Shipping in Europe 24/72H
    Free over €80

  • SAFETY

    The security of your data matters to us!


    We are fully compliant with the European GDPR regarding Privacy and Processing of personal data.


    Payments you make on our site are 100% safe and guaranteed.

  • RETURNS

    Fast returns through do-it-yourself portal and 14 days to reconsider.


    Fast and free replacements for incorrect or non-compliant products delivered.

NaN of -Infinity

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: www.farmadati.it

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.